120
Participants
Start Date
December 31, 2011
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
Lacosamide
"50 mg and 100 mg lacosamide tablets will be combined and taken in two equal doses per day to provide the required total daily dosage of 100 - 600 mg/day. Subjects were titrated to a minimum of 200 mg/ day during the Treatment Period.~Maximum duration of study drug administration is approximately 23 weeks."
110, Huntsville
004, Phoenix
001, Fresno
008, Orange
030, Oxnard
108, Sacramento
025, Bradenton
015, Ocala
049, Panama City
114, Port Charlotte
012, Sarasota
014, Tampa
003, Wellington
123, Louisville
006, Hammond
112, Waldorf
129, Golden Valley
023, Springfield
088, Missoula
020, Camden
131, Greensboro
002, Akron
027, Canton
022, Columbus
005, Dayton
013, Oklahoma City
028, Lubbock
017, Salt Lake City
139, Madison
024, Milwaukee
075, Chatswood
079, Parkville
036, Rousse
037, Sofia
080, Sofia
081, Sofia
082, Sofia
059, Aarhus
087, Copenhagen
042, Angers
040, Limoges
046, Paris
065, Bielefeld
066, Hamburg
068, Tübingen
096, Bucharest
099, Bucharest
097, Lasi
038, Târgu Mureş
095, Târgu Mureş
051, Manresa
053, Oviedo
050, Seville
102, Gothenburg
Lead Sponsor
UCB Pharma
INDUSTRY